A kinetic mass balance model for 1,5-anhydroglucitol: Applications to monitoring of glycemic control

American Journal of Physiology - Endocrinology and Metabolism

Volumn 273, Issue 4 36-4, 1997, Pages

  Stickle, Douglas ^a   Turk, John ^a,b  

^a Division of Laboratory Medicine   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Glycated hemoglobin; Hyperglycemia; Mathematical model

Indexed keywords

1,5 ANHYDROSORBITOL;

ADULT; CEREBROSPINAL FLUID; COMPARTMENT MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; KINETICS; MATHEMATICAL MODEL; MONITORING; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; STEADY STATE; URINARY EXCRETION;

EID: 0030720088     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.273.4.e821     Document Type: Review

References (16)

1. Akanuma, Y., M. Morita, N. Fukuzawa, T. Yamanouchi, and H. Akanuma. Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients. Diabetologia 31: 831-835, 1988.
2. Akanuma, H., K. Ogawa, Y. Lee, and Y. Akanuma. Reduced levels of plasma 1,5-anhydroglucitol in diabetic patients. J. Biochem. 90: 157-162, 1981.
3. Aoyagi, T., H. Akanuma, T. Wada, T. Sakaguchi, T. Kobayashi, and H. Umezawa. Changes in relationship between blood glucose level and plasma 1,5-anhydroglucitol level in KK mice. Biochem. Int. 18: 599-603, 1989.
4. Emoto, M., T. Tabata, T. Inoue, Y. Nishizawa, and H. Morii. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Nephron 61: 181-186, 1992.
5. Frattali, A. L., and B. A. Wolf. 1,5-Anhydroglucitol: a novel serum marker for screening and monitoring diabetes mellitus? Clin. Chem. 40: 1991-1993, 1994.
6. Funasako, M., M. Taniji, K. Fujimoto, M. Ohata, Y. Higashimoto, K. Uetani, T. Suruda, S. Nakai, H. Fujimoto, and Y. Sakagami. Effect of aging on plasma 1,5-anhydroglucitol levels in humans and rats. Diabetes Res. Clin. Pract. 25: 35-41, 1994.
7. Harris, M., and M. Modan. Screening for NIDDM. Why is there no national program? Diabetes Care 17: 440-444, 1994.
8. Kametani, S., Y. Hashimoto, T. Yamanouchi, Y. Akanuma, and H. Akanuma. Reduced renal reabsorption of 1,5-anhydro-D-glucitol in diabetic rats and mice. J. Biochem. 102: 1599-1607, 1987.
9. Kishimoto, M., Y. Yamasaki, M. Kubota, K. Arai, T. Morishima, R. Kawamori, and T. Kamada. 1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes Care 18: 1156-1159, 1995.
10. Knowler, W. Screening for NIDDM. Opportunities for detection, treatment, and prevention. Diabetes Care 17: 445-450, 1994.
11. Kusmierz, J., J. J. DeGeorge, D. Sweeney, C. May, and S. I. Rapoport. Quantitative analysis of polyols in human plasma and cerebrospinal fluid. J. Chromatog. 497: 39-48, 1989.
12. Mortensen, H., A. Volund, and C. Christophersen. Glucosylation of human haemoglobin A. Dynamic variation in HbA1c described by a biokinetic model. Clin. Chem. Acta 136: 75-81, 1984.
13. Nagai, M., K. Sakata, H. Yanagawa, H. Sueta, T. Tanaka, and S. Shirahama. Efficacy of hemoglobin-A1c, fructosamine, and 1,5-anhydroglucitol in community screening for diabetes mellitus. Jpn. J. Public Health 40: 205-212, 1993.
14. Namba, N., F. Watanabe, M. Tokuda, M. Mino, and E. Furuya. A new method of quantitating serum and urinary levels of 1,5-anhydroglucitol in insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 24: 55-61, 1994.
15. Niwa, T., L. Dewald, J. Sone, T. Miyazaki, and M. Kajita. Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry. Clin. Chem. 40: 260-264, 1994.
16. Pitkanen, E. Serum 1,5-anhydroglucitol in normal subjects and in patients with insulin-dependent diabetes mellitus. Scand. J. Clin. Lab. Invest. 42: 445-448, 1982.